ICLR

ICON Public Limited Company

$182.98

−$0.80 (0.44%)Oct 27 close

Healthcare Compare Technicals

1M 3M 6M 1Y 2Y

ICLRSPY

Wall St. Highest PT $215.00 (+17.5%) Wall St. Avg PT $188.24 (+2.9%)

Underwater Drawdown %Max DD -60.5%Current -9.8%

Relative Strength vs SPY-13.0% vs SPYUnderperforming

+$8.79 (5.05%)

+$10.65 (6.18%)

+$2.74 (1.52%)

+$80.49 (78.53%)

YTD

+$0.76 (0.42%)

+$0.95 (0.52%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar

Wall Street analyst consensus

Buy

17 analysts · mean score 2.00

1 = Strong Buy · 5 = Sell

Wall Street consensus

Analyst price targets

Current price$182.98

Average target$188.24

+$5.26 (+2.9%) upsideaverage target vs current price

CurrentAverageMedian

Low$155.00

Median$186.00

High$215.00

12-month Wall Street target range

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$14.3B

P/E (last 12 months)195.0

P/E (next 12 months, estimated)15.7

52-week range$66.57 – $203.91

Revenue growth (latest quarter vs a year ago)+1.2%

Dividend yieldNo dividend

Analyst consensusBuy (17)

Average analyst price target$188.24 (+3%)

What they do

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.

Healthcare · Diagnostics & Research

Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

No sector grades for ICLR yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth

Outside this model's universe or screens

Momentum Top 15

Outside this model's universe or screens

Momentum Blend

Not in the current book

New Highs Growth

Outside this model's universe or screens

SURVYR. Barbell Momentum & T-Bill Shield

Outside this model's universe or screens

SURVYR. Physical AI Grid & Power

Outside this model's universe or screens

SURVYR. Long Book

Not in the current book

Earnings & events

ICLR earningsNo upcoming date on file

Last 4 quarters · EPS vs estimate

Jul 29, 2026$2.56est $2.52+1.7%Above estimates

Jun 23, 2026$2.50est $2.43+3.0%Above estimates

May 27, 2026$2.52est $3.11−18.9%Below estimates

Oct 22, 2025$3.31est $3.28+1.0%In line with estimates

In line = within 1% of the estimate.

EstimateActual (beat)Actual (miss)

News & catalysts

More news

No recent headlines.

Insider trades

Lyons Emer